Independent participant-perception study

NeoTight Eye — visible customer results at four and six weeks

NeoTight built on its first-use response: by week six, participants described brighter-looking dark circles, less-visible bags and puffiness, and nourishing care for delicate eye-area skin.

updated 2026-07-28 · scope, timing & source status

Public source: Independent NeoTight Eye participant questionnaire
Source access: 2 direct source links are available
Last verified: 2026-07-28
Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
What the clinical found: At week six, 84.85% of participants agreed NeoTight visibly brightened dark under-eye circles and improved the look of bags and puffiness; 100% agreed it nourished the delicate skin around the eyes.

Evidence record scope master. A reusable evidence header with fields for tested article, record type, method, sample, endpoint, duration, result, and qualification.

what the evidence reports

finding 01

71.88% agreement

At week 4, 71.88% of participants agreed that NeoTight visibly brightened dark under-eye circles.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: visibly brightened dark under-eye circles
Study timing: 4 weeks

finding 02

84.85% agreement

At week 6, 84.85% of participants agreed that NeoTight visibly brightened dark under-eye circles.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: visibly brightened dark under-eye circles
Study timing: 6 weeks

finding 03

68.75% agreement

At week 4, 68.75% of participants agreed that NeoTight visibly improved the look of under-eye bags and puffiness.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: visibly improved the look of under-eye bags and puffiness
Study timing: 4 weeks

finding 04

84.85% agreement

At week 6, 84.85% of participants agreed that NeoTight visibly improved the look of under-eye bags and puffiness.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: visibly improved the look of under-eye bags and puffiness
Study timing: 6 weeks

finding 05

96.88% agreement

At week 4, 96.88% of participants agreed that NeoTight increased smoothness around the eye area.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: increased smoothness around the eye area
Study timing: 4 weeks

finding 06

93.94% agreement

At week 6, 93.94% of participants agreed that NeoTight increased smoothness around the eye area.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: increased smoothness around the eye area
Study timing: 6 weeks

finding 07

78.13% agreement

At week 4, 78.13% of participants agreed that NeoTight made tired-looking eyes look more energized.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: made tired-looking eyes look more energized
Study timing: 4 weeks

finding 08

84.85% agreement

At week 6, 84.85% of participants agreed that NeoTight made tired-looking eyes look more energized.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: made tired-looking eyes look more energized
Study timing: 6 weeks

finding 09

93.75% agreement

At week 4, 93.75% of participants agreed that NeoTight's lightweight texture absorbed quickly, leaving skin soothed and refreshed.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: lightweight texture absorbed quickly, leaving skin soothed and refreshed
Study timing: 4 weeks

finding 10

93.94% agreement

At week 6, 93.94% of participants agreed that NeoTight's lightweight texture absorbed quickly, leaving skin soothed and refreshed.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: lightweight texture absorbed quickly, leaving skin soothed and refreshed
Study timing: 6 weeks

finding 11

68.75% agreement

At week 4, 68.75% of participants agreed that NeoTight improved the look of fine lines and wrinkles around the eyes.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: improved the look of fine lines and wrinkles around the eyes
Study timing: 4 weeks

finding 12

75.76% agreement

At week 6, 75.76% of participants agreed that NeoTight improved the look of fine lines and wrinkles around the eyes.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: improved the look of fine lines and wrinkles around the eyes
Study timing: 6 weeks

finding 13

68.75% agreement

At week 4, 68.75% of participants agreed that NeoTight smoothed skin for a filter-like look.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: smoothed skin for a filter-like look
Study timing: 4 weeks

finding 14

72.73% agreement

At week 6, 72.73% of participants agreed that NeoTight smoothed skin for a filter-like look.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: smoothed skin for a filter-like look
Study timing: 6 weeks

finding 15

75.00% agreement

At week 4, 75.00% of participants agreed that NeoTight helped eyes feel less tired and more energetic.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: helped eyes feel less tired and more energetic
Study timing: 4 weeks

finding 16

81.82% agreement

At week 6, 81.82% of participants agreed that NeoTight helped eyes feel less tired and more energetic.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: helped eyes feel less tired and more energetic
Study timing: 6 weeks

finding 17

65.63% agreement

At week 4, 65.63% of participants agreed that NeoTight reduced the appearance of crow's feet.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of crow's feet
Study timing: 4 weeks

finding 18

66.67% agreement

At week 6, 66.67% of participants agreed that NeoTight reduced the appearance of crow's feet.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of crow's feet
Study timing: 6 weeks

finding 19

50.00% agreement

At week 4, 50.00% of participants agreed that NeoTight reduced the appearance of sagging eyelids.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of sagging eyelids
Study timing: 4 weeks

finding 20

63.64% agreement

At week 6, 63.64% of participants agreed that NeoTight reduced the appearance of sagging eyelids.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of sagging eyelids
Study timing: 6 weeks

finding 21

71.88% agreement

At week 4, 71.88% of participants agreed that NeoTight reduced the appearance of dark circles.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of dark circles
Study timing: 4 weeks

finding 22

69.70% agreement

At week 6, 69.70% of participants agreed that NeoTight reduced the appearance of dark circles.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of dark circles
Study timing: 6 weeks

finding 23

68.75% agreement

At week 4, 68.75% of participants agreed that NeoTight reduced the appearance of eye bags.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of eye bags
Study timing: 4 weeks

finding 24

66.67% agreement

At week 6, 66.67% of participants agreed that NeoTight reduced the appearance of eye bags.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: reduced the appearance of eye bags
Study timing: 6 weeks

finding 25

84.38% agreement

At week 4, 84.38% of participants agreed that NeoTight increased the luminosity of skin.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: increased the luminosity of skin
Study timing: 4 weeks

finding 26

87.88% agreement

At week 6, 87.88% of participants agreed that NeoTight increased the luminosity of skin.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: increased the luminosity of skin
Study timing: 6 weeks

finding 27

93.75% agreement

At week 4, 93.75% of participants agreed that NeoTight nourished the delicate skin around the eyes.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: nourished the delicate skin around the eyes
Study timing: 4 weeks

finding 28

100.00% agreement

At week 6, 100.00% of participants agreed that NeoTight nourished the delicate skin around the eyes.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: nourished the delicate skin around the eyes
Study timing: 6 weeks

finding 29

56.25% agreement

At week 4, 56.25% of participants agreed that NeoTight lifted and defined eye contours.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: lifted and defined eye contours
Study timing: 4 weeks

finding 30

66.67% agreement

At week 6, 66.67% of participants agreed that NeoTight lifted and defined eye contours.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: lifted and defined eye contours
Study timing: 6 weeks

finding 31

68.75% agreement

At week 4, 68.75% of participants agreed that NeoTight improved the look of eyelid crepiness.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: improved the look of eyelid crepiness
Study timing: 4 weeks

finding 32

78.79% agreement

At week 6, 78.79% of participants agreed that NeoTight improved the look of eyelid crepiness.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: improved the look of eyelid crepiness
Study timing: 6 weeks

finding 33

65.63% agreement

At week 4, 65.63% of participants agreed that NeoTight appeared to fill in fine lines and wrinkles.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: appeared to fill in fine lines and wrinkles
Study timing: 4 weeks

finding 34

66.67% agreement

At week 6, 66.67% of participants agreed that NeoTight appeared to fill in fine lines and wrinkles.

Clinical subject: NeoTight Eye participant-perceived brightening, smoothness, nourishment, and visible eye-area appearance after continued use
Clinical endpoint: participant agreement: appeared to fill in fine lines and wrinkles
Study timing: 6 weeks

reading the findings

what these findings support

NeoTight kept building visible customer confidence. At week six, 84.85% of participants agreed it visibly brightened dark under-eye circles and improved the look of bags and puffiness; 100% agreed it nourished the delicate skin around the eyes. All 17 continuing-use statements received favorable responses at both week four and week six.